
ACADIA PHARMACEUTICALS INC — Investor Relations & Filings
ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer) | 2026-05-06 | English | |
| 4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer) | 2026-03-27 | English | |
| 4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer) | 2026-03-27 | English | |
| 4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer) | 2026-03-27 | English | |
| 4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer) | 2026-03-27 | English |
Browse filings by year
18 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hanmi Pharm. Co., Ltd.
A research-oriented biopharmaceutical company developing an…
|
128940 | KR | Manufacturing |
|
Hanmi Science Co.,Ltd
A holding company managing subsidiaries in the pharmaceutic…
|
008930 | KR | Manufacturing |
|
Hansa Biopharma
Develops antibody-cleaving enzyme technology for rare immun…
|
HNSA | SE | Manufacturing |
|
Hansoh Pharmaceutical Group Company Limited
Leading innovation-driven biopharmaceutical enterprise deve…
|
3692 | KY | Manufacturing |
|
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Clinical-stage biopharma developing immuno-oncology therapi…
|
3378 | HK | Manufacturing |
|
Harbin Fuerjia Technology Co., Ltd.
Develops medical dressings and functional cosmetics for ski…
|
301371 | CN | Manufacturing |
|
HARBIN GLORIA PHARMACEUTICALS Co., LTD
Develops and produces drugs for cardiovascular, orthopedic,…
|
002437 | CN | Manufacturing |
|
HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.
Produces injections and oral drugs for cardiovascular, gast…
|
002900 | CN | Manufacturing |
|
Harbin Pharmaceutical Group Co.,Ltd.
Researches and manufactures pharmaceuticals, OTC drugs, and…
|
600664 | CN | Manufacturing |
|
Harmony Biosciences Holdings, Inc.
Develops and commercializes therapies for rare neurological…
|
HRMY | US | Manufacturing |
ACADIA PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31237/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31237 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31237 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31237 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31237}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACADIA PHARMACEUTICALS INC (id: 31237)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.